ArticleDiabetology international2017

Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial.

Akiko Kameda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.